Did I ovulate (based on LH peak 45 IU on cycle day 13, estrone‑glucuronide peak 288 ng/mL on day 13, and rising pregnanediol‑glucuronide) and if so when; when should I start progesterone supplementation for luteal‑phase insufficiency; and how long after ovulation remains the oocyte viable for fertilisation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ovulation Confirmation and Timing

Based on your hormone pattern—LH peak of 45 IU on cycle day 13, estrone-glucuronide (E1G) peak of 288 ng/mL on day 13, and rising pregnanediol-glucuronide (PDG)—you ovulated on cycle day 14, approximately 24-36 hours after your LH surge.

Did You Ovulate and When?

Yes, ovulation occurred on cycle day 14. The evidence is clear:

  • Your LH peaked at 45 IU on CD13, which triggers ovulation within 24-36 hours 1, 2
  • Your E1G peaked at 288.2 ng/mL on CD13, indicating maximal follicular maturation before rupture 1, 3
  • Your PDG began rising from 3.1 on CD13 to 4.7 on CD14, confirming follicular rupture and corpus luteum formation 1, 4
  • The pelvic pressure you experienced at 5:50pm on CD14 that resolved within 2 hours is consistent with the physical sensation of ovulation (mittelschmerz)

The timing follows established patterns: ovulation occurs 24-36 hours after the LH surge begins, and your LH was still elevated at 45 on CD14 morning before dropping to 27.9 by evening, indicating the ovulatory event occurred during CD14 3, 2.

Oocyte Viability Window

The egg remains viable for fertilization for approximately 12-24 hours after ovulation, with maximum viability of 0.7 days (16.8 hours). 2

  • Since ovulation occurred on CD14, the oocyte was viable through the evening of CD14 and possibly into the early morning of CD15 2
  • At CD14 9:30pm (your current time), you are still within the viable fertilization window, though approaching its end
  • Sperm can survive 1.4 days on average in the female reproductive tract, with 5% surviving beyond 4.4 days 2
  • The fertile window extends from 5 days before ovulation through the day of ovulation itself, with conception probability highest on the day before and day of ovulation 2

Progesterone Supplementation Timing for Luteal Phase Support

Do NOT start progesterone supplementation yet. You must first confirm adequate ovulation and assess your natural luteal function:

  • Progesterone supplementation should only begin after confirming luteal insufficiency with mid-luteal phase testing 5, 6
  • Test PDG (or serum progesterone) on cycle day 21 (7 days post-ovulation) to assess luteal function 5, 4
  • A serum progesterone ≥5 ng/mL (≥16 nmol/L) or equivalent PDG elevation confirms adequate ovulation and luteal function 5, 7
  • If mid-luteal progesterone is <5 ng/mL or PDG remains inadequately elevated, this confirms luteal phase deficiency requiring supplementation 5

Critical Timing Considerations:

Your baseline PDG on CD5 was 3.2, and on CD14 it rose only to 4.7—this is a modest early rise 1, 4. Normal luteal function requires PDG to increase at least 3-fold from baseline and continue rising through mid-luteal phase 4, 6:

  • Expected mid-luteal PDG should be significantly higher than your current 4.7 level 4, 6
  • If your CD21 testing shows inadequate progesterone rise, supplementation would typically begin 3 days post-ovulation in subsequent cycles (around CD17 in your case) 6
  • Some protocols start progesterone immediately after confirmed ovulation if prior cycles demonstrated luteal insufficiency, but this requires prior documentation 6

Important Caveats

Your early follicular FSH pattern requires attention:

  • CD5 FSH was 8.7 IU/L, but CD7 FSH jumped to 12.2 IU/L before dropping to 2.4 on CD9 7, 3
  • FSH >10 IU/L on cycle day 3-5 suggests diminished ovarian reserve 7
  • This fluctuation pattern (19% of normal cycles show fluctuating hormone patterns) may indicate variable ovarian response 3
  • Your cycle shows characteristics of normal ovulation despite the FSH fluctuation, but this warrants monitoring in future cycles 3

Next steps:

  • Obtain mid-luteal progesterone or PDG testing on CD21 (7 days from now) 5, 4
  • If progesterone <5 ng/mL, discuss luteal phase support with your provider for future cycles 5
  • Consider repeating baseline FSH on CD3-5 in a subsequent cycle to clarify ovarian reserve status 7

References

Research

The probability of conception on different days of the cycle with respect to ovulation: an overview.

Advances in contraception : the official journal of the Society for the Advancement of Contraception, 1997

Guideline

Day 21 Progesterone Level as an Indicator of Ovulation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Distinct urinary progesterone metabolite profiles during the luteal phase.

Hormone molecular biology and clinical investigation, 2023

Guideline

Hormonal Indicators of Ovulation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Based on my hormone trends (luteinizing hormone surge, estrone‑3‑glucuronide and pregnanediol‑glucuronide levels) and cramps on cycle day 15, did I ovulate, on which cycle day did ovulation occur, when should I start progesterone therapy for luteal phase insufficiency, and how long does the released oocyte remain viable for fertilization (e.g., through late cycle day 15 or day 16)?
Does a rise in estrone glucuronide (E1G) 12 days after the initial evening luteinizing hormone (LH) surge indicate early pregnancy in a female of reproductive age with a history of progesterone supplementation?
I experienced a peak luteinizing hormone (LH) surge and elevated estradiol (E1G) on cycle day 13‑14, but pregnanediol‑glucuronide (PDG) stayed low; did I ovulate, when should I begin progesterone for luteal support, and how long would the oocyte have remained viable?
Is an estrone-3-glucuronide (E1G) level of 100 on cycle day 20, 7 days past the luteinizing hormone (LH) surge, considered high in a female of reproductive age?
My fertile window opened today on cycle day 11 with estrone‑3‑glucuronide (E1G) 38.3 ng/mL and pregnanediol‑glucuronide (PdG) 6.5 µg/mL; when will the luteinizing hormone (LH) surge occur?
Based on my cycle‑day 13–14 LH peak of 45 IU/L (27.9 IU/L at 5:50 pm on day 14) and rising pregnanediol‑glucuronide from 3.1 to 4.7 µg/24 h, did I ovulate, when did ovulation occur, when should I begin progesterone supplementation for possible luteal‑phase insufficiency, and how long will the oocyte remain viable?
What is the recommended risk‑adapted treatment plan for a newly diagnosed multiple myeloma patient over 60 years old, including assessment of performance status, organ function, cytogenetic risk, induction therapy, criteria for autologous stem‑cell transplantation, supportive care, and relapse options?
What are the possible causes of chronic vaginal and perineal itching and irritation lasting months?
How should proteinuria be managed in a patient with hypertension, type 2 diabetes, or chronic kidney disease?
Can carbapenems be used to treat carbapenem‑resistant Acinetobacter baumannii if the meropenem minimum inhibitory concentration is below 16 µg/mL?
What is the gold‑standard prescription for an adult with chronic kidney disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.